What is Head Lice Drug Market?
Head lice are small, wingless, blood-sucking insects that attack the hair. They feed on the blood of your scalp, which causes irritation or sometimes large pimples on the head. The male lice are much larger compared to the female lice. Head lice are transmissible if you get infected with head lice. Head lice are characterized by symptoms such as severe itching, tingling sensation when the hair moves, and sores on the scalp, neck, and shoulders. Head lice infestation is caused by poor personal hygiene. Head lice can be treated with over-the-counter drugs and prescribed drugs. There are many treatment options available to get rid of head lice, but most treatments need to be used twice or more. The second treatment takes place after a week to kill any newly hatched nits.
The market study is being classified by Type (OTC Medication [Permethrin, Pyrethrin, Other] and Prescription Medication [Ivermectin, Spinosad, Malathion, Other]), by Application (Children and Adult) and major geographies with country level break-up.
Bayer AG (Germany), Alliance Pharmaceuticals Ltd. (United Kingdom), Omega Pharma (Belgium), Arbor Pharmaceuticals Inc. (United States), Prestige Consumer Healthcare Inc. (United States), GlaxoSmithKline (United Kingdom), Merck & Co. (United States), ParaPRO Pharmaceuticals (United States), Fleming Medical Ltd. (Ireland), Perrigo Company plc (Ireland), Stada Arzneimittel (Germany), Reckitt Benckiser Group plc (United Kingdom), Cerecor Inc. (United States) and Medexus Pharmaceuticals (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Nuvo Pharmaceuticals (Canada), Piedmont Pharmaceuticals LLC (United States) and ICB Pharma (Poland).
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that European Players will contribute to the maximum growth of Global Head Lice Drug market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Head Lice Drug market by Type, Application and Region.
On the basis of geography, the market of Head Lice Drug has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- The Increasing Prevalence and Growing Population of Children Who Are More Prone To Lice Infestation
- Lack of Awareness Regarding Personal Hygiene
- Easy Availability of Lice Treatment Products
- New Launches and Emerging New Markets
- The High Prevalence and High Disposable Income
- Lack of Patience in Human Patients
- Increasing Healthcare Expenditure
- The Rising Penetration of Market Players
- Greater Efficiency in Treatment of Head Lice Requires Constant Combing Regimes, Which Lead To Discomfort in Patients
Market Leaders and some development strategies
In December 2017, Alliance Pharmaceuticals Ltd had acquired the worldwide rights for Vamousse, which is a head lice product from TyraTech Inc. for USD 17.5 million. This acquisition hereby represented a third major international growth brand and is thereby expected to enhance the revenue from the sales of Vamousse.
Key Target AudienceManufacturers of Head Lice Drug, Suppliers and Distributors of Head Lice Drug, Potential Investors, Market Research Firms, Regulatory Bodies, End-Users and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase